'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
'First-in-class' precision cancer drug shows promising results in Phase I trial
A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial.
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
No comments:
Post a Comment